Show simple item record

Authordc.contributor.authorNúñez Vergara, Luis es_CL
Authordc.contributor.authorSquella Serrano, Juanes_CL
Authordc.contributor.authorBollo Dragnic, Soledad es_CL
Authordc.contributor.authorMarín Catalán, Rigoberto es_CL
Authordc.contributor.authorPino, L. es_CL
Authordc.contributor.authorDíaz Araya, Guillermo 
Authordc.contributor.authorLetelier Muñoz, María Eugenia es_CL
Admission datedc.date.accessioned2009-08-26T11:59:05Z
Available datedc.date.available2009-08-26T11:59:05Z
Publication datedc.date.issued1998-01
Cita de ítemdc.identifier.citationGENERAL PHARMACOLOGY 30(1): 85-87en
Identifierdc.identifier.issn0306-3623
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/120785
Abstractdc.description.abstract1. Isradipine and lacidipine, two new drugs that are members of the nitro-aryl-1,4-dihydropyridine family, produced inhibition of both growth cultures and oxygen consumption on epimastigotes of Trypanosoma cruzi Tulahuen strain, at micromolar concentrations. 2. Isradipine was found to be the most potent derivative in both, in growth cultures (I-50=20.8 mu M) and in vivo oxygen uptake (I-50=31.1 mu M). 3. Diltiazem and verapamil, two well-known calcium channel antagonists, lacked inhibitory activity, even at a 100 mu M concentration. 4. The present findings indicate that the trypanocide effects exerted by isradipine and lacidipine are not related with a disruption of the calcium homeostasis of the parasite.en
Lenguagedc.language.isoenen
Publisherdc.publisherPERGAMON-ELSEVIER SCIENCE LTDen
Keywordsdc.subjectTrypanosoma cruzien
Títulodc.titleIsradipine and lacidipine: Effects in vivo and in vitro on Trypanosoma cruzi epimastigotesen
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record